Industries > Pharma > Tissue Diagnostics Market Report 2019-2029

Tissue Diagnostics Market Report 2019-2029

Forecasts by Product (Consumables, Instruments), by Product (Immunohistochemistry, in Situ Hybridization, Digital Pathology, Others), by Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, Others), by End User (Hospitals, Research Labs, Pharmaceutical Companies, Research Organizations) Plus Analysis of Leading Companies

PAGES: 125
PRODUCT CODE: PHA0640
SUBMARKET:

DOWNLOAD FREE SAMPLE
WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0640 Category: Tag:

Visiongain’s new report the Tissue Diagnostics Market Report 2019-2029: Forecasts by Product (Consumables, Instruments), by Product (Immunohistochemistry, in Situ Hybridization, Digital Pathology, Others), by Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, Others), by End User (Hospitals, Research Labs, Pharmaceutical Companies, Research Organizations), plus analysis of leading companies operating in the global tissue diagnostics market.

List of companies identified in global tissue diagnostics market report are Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Product, Siemens Healthineers, bioMérieux SA, Johnson & Johnson Services, Inc., GE Healthcare, and DiaGenic.

Tissue Diagnostics Market Report 2019-2029, By Product

– Consumables
– Antibodies
– Kits
– Reagents
– Probes

– Instruments
– Slide-Staining Systems
– Scanners
– Tissue-Processing Systems
– Others

Tissue Diagnostics Market Report 2019-2029, By Technology
– Immunohistochemistry
– in Situ Hybridization
– Digital Pathology
– Others

Tissue Diagnostics Market Report 2019-2029, By Diseases
– Breast Cancer
– Gastric Cancer
– Lymphoma
– Prostate Cancer
– Non-Small Cell Lung Cancer
– Others

Tissue Diagnostics Market Analysis , By End User
– Hospitals
– Research Labs
– Pharmaceutical Companies
– Research Organisations

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Tissue Diagnostics Market Report 2019-2029

    Download sample pages

    Complete the form below to download your free sample pages for Tissue Diagnostics Market Report 2019-2029

      Latest Pharma news

      Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

      The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

      18 April 2024

      READ

      Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

      The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

      17 April 2024

      READ

      Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

      The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

      12 April 2024

      READ

      Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

      The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

      11 April 2024

      READ